{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:23:50Z","timestamp":1793258630103,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bcmd.2023.102778","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T19:38:17Z","timestamp":1687462697000},"page":"102778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Acquired elliptocytosis in chronic myeloid neoplasms: An enigmatic relationship to acquired red cell membrane protein and genetic abnormalities"],"prefix":"10.1016","volume":"103","author":[{"given":"Marshall A.","family":"Lichtman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Sham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcmd.2023.102778_bb0005","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ajcp\/82.3.354","article-title":"Marked elliptocytosis and schistocytosis in hematopoietic dysplasia","volume":"82","author":"Hartz","year":"1984","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.bcmd.2023.102778_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000206351","article-title":"Elliptocytosis preceding myelofibrosis in a patient with polycythemia vera","volume":"72","author":"Djaldetti","year":"1984","journal-title":"Acta Haematol."},{"issue":"3","key":"10.1016\/j.bcmd.2023.102778_bb0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000206114","article-title":"Elliptocytosis and schistocytosis in myelodysplasia: report of two cases","volume":"75","author":"Rummens","year":"1986","journal-title":"Acta Haematol."},{"issue":"2","key":"10.1016\/j.bcmd.2023.102778_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.1993.tb03183.x","article-title":"Abnormal erythrocyte band 4.1 protein in myelodysplastic syndrome with elliptocytosis","volume":"85","author":"Ideguchi","year":"1993","journal-title":"Brit. J. Haematol."},{"issue":"4","key":"10.1016\/j.bcmd.2023.102778_bb0025","first-page":"395","article-title":"Decreased deformability of red cells in refractory anemia and the abnormality of the membrane skeleton","volume":"31","author":"Maeda","year":"1994","journal-title":"Biorheology"},{"key":"10.1016\/j.bcmd.2023.102778_bb0030","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ajcp\/106.5.680","article-title":"Hematologic disorders associated with deletion of chromosome 20q: a clinicopathologic study of 107 patients","volume":"106","author":"Kurtin","year":"1996","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.bcmd.2023.102778_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-4608(96)00334-2","article-title":"Isochromosome 14q in refractory anemia","volume":"97","author":"Boavida","year":"1997","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"10.1016\/j.bcmd.2023.102778_bb0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0165-4608(98)00135-6","article-title":"Elliptocytosis in myelodysplastic syndrome associated with translocation (1;5)(p10;q10) and deletion of 20q","volume":"108","author":"Ishida","year":"1999","journal-title":"Cancer Genet. Cytogenet."},{"issue":"1","key":"10.1016\/j.bcmd.2023.102778_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.0141-9854.2003.00583.x","article-title":"Protein 4.1 deficiency and deletion of chromosome 20q are associated with acquired elliptocytosis in myelodysplastic syndrome","volume":"26","author":"Hur","year":"2004","journal-title":"Clin. Lab. Haematol."},{"issue":"11","key":"10.1016\/j.bcmd.2023.102778_bb0050","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1182\/blood.V106.11.4927.4927","article-title":"Marked elliptocytosis in Myelodysplastic Syndromes (MDS) is associated to deletion of chromosome 20q","volume":"106","author":"Baweja","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcmd.2023.102778_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajh.21088","article-title":"Association between myeloid malignancies and acquired deficit in protein 4.1R: a retrospective analysis of six patients","volume":"83","author":"Alanio-Br\u00e9chot","year":"2007","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.bcmd.2023.102778_bb0060","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2012-06-432237","article-title":"Acquired elliptocytosis of myelodysplastic syndrome","volume":"121","author":"Knight","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102778_bb0065","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1182\/blood-2016-03-703876","article-title":"Acquired elliptocytosis in the setting of a refractory anemia with excess blasts and del(20q)","volume":"127","author":"Boutault","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102778_bb0070","first-page":"3625946","article-title":"Acquired elliptocytosis as a manifestation of myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia","volume":"2017","author":"Kjelland","year":"2017","journal-title":"Case Rep. Hematol."},{"key":"10.1016\/j.bcmd.2023.102778_bb0075","first-page":"6819172","article-title":"Acquired elliptocytosis as a manifestation of myelodysplastic syndrome associated with deletion of chromosome 20q","volume":"2018","author":"Manthri","year":"2018","journal-title":"Case Rep. Hematol."},{"issue":"2","key":"10.1016\/j.bcmd.2023.102778_bb0080","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bjh.15746","article-title":"Acquired elliptocytosis in a patient with a myelodysplastic syndrome associated with 20q deletion","volume":"185","author":"Quiroz-Cervantes","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.bcmd.2023.102778_bb0085","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000517","article-title":"Reticulocytosis as a whistleblower: a rare case of acquired elliptocytosis in a myelodysplastic syndrome patient with trisomy 8","volume":"5","author":"Hage-Sleiman","year":"2021","journal-title":"Hemasphere"},{"issue":"8","key":"10.1016\/j.bcmd.2023.102778_bb0090","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00277-020-04368-w","article-title":"Acquired elliptocytosis as presenting sign of a myelodysplastic syndrome associated with deletion of chromosome 20 and mutations in TET2, DNMT3A, and U2AF1","volume":"100","author":"Robier","year":"2021","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.bcmd.2023.102778_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/bjh.17683","article-title":"Acquired elliptocytosis in a patient with myelodysplastic syndrome harbouring a novel unbalanced whole-arm translocation, der(14;20)(q10;p10)","volume":"196","author":"Manabe","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.bcmd.2023.102778_bb0100","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0145-2126(93)90038-M","article-title":"De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features?","volume":"17","author":"Wattel","year":"1993","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.bcmd.2023.102778_bb0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00277-011-1286-0","article-title":"Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study","volume":"91","author":"Mullier","year":"2012","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.bcmd.2023.102778_bb0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.seminhematol.2004.01.003","article-title":"Hereditary elliptocytosis: spectrin and protein 4.1R","volume":"41","author":"Gallagher","year":"2004","journal-title":"Semin. Hematol."},{"issue":"1","key":"10.1016\/j.bcmd.2023.102778_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2006.03.005","article-title":"The molecular basis of hereditary red cell membrane disorders","volume":"21","author":"Delaunay","year":"2007","journal-title":"Blood Rev."},{"issue":"5","key":"10.1016\/j.bcmd.2023.102778_bb0120","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/bjh.13778","article-title":"The human Kell blood group binds the erythroid 4.1R protein: new insights into the 4.1R-dependent red cell membrane complex","volume":"171","author":"Azouzi","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.bcmd.2023.102778_bb0125","first-page":"209","article-title":"Molecular genetics of hereditary elliptocytosis and hereditary spherocytosis","volume":"39","author":"Delaunay","year":"1996","journal-title":"Ann. Genet."},{"issue":"3","key":"10.1016\/j.bcmd.2023.102778_bb0130","first-page":"298","article-title":"Protein 4.1, a multifunctional protein of the erythrocyte membrane skeleton: structure and functions in erythrocytes and nonerythroid cells","volume":"72","author":"Takakuwa","year":"2000","journal-title":"Int. J. Hematol."},{"issue":"4","key":"10.1016\/j.bcmd.2023.102778_bb0135","first-page":"231","article-title":"Protein 4.1, a component of the erythrocyte membrane skeleton and its related homologue proteins forming the protein 4.1\/FERM superfamily","volume":"44","author":"Diakowski","year":"2006","journal-title":"Folia Histochem. Cytobiol."},{"issue":"6","key":"10.1016\/j.bcmd.2023.102778_bb0140","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V78.6.1603.1603","article-title":"Molecular basis for elliptocytosis associated with glycophorin C and D deficiency in the Leach phenotype","volume":"78","author":"Telen","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2023.102778_bb0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcmd.2016.07.003","article-title":"Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis","volume":"61","author":"Niss","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2023.102778_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146796","article-title":"Unravelling the genetic and phenotypic heterogeneity of SPTA1 gene variants in hereditary elliptocytosis and hereditary pyropoikilocytosis patients using next-generation sequencing","volume":"843","author":"Anil More","year":"2022","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.bcmd.2023.102778_bb0155","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/ejh.13951","article-title":"Clinical utility of targeted next-generation sequencing panel in routine diagnosis of hereditary hemolytic anemia: a national reference laboratory experience","volume":"110","author":"Agarwal","year":"2023","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102778_bb0160","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fphys.2020.00357","article-title":"Expression of south east Asian ovalocytic band 3 disrupts erythroblast cytokinesis and reticulocyte maturation","volume":"11","author":"Flatt","year":"2020","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.bcmd.2023.102778_bb0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1523-1755.2002.00417.x","article-title":"Band 3 mutations, distal renal tubular acidosis, and Southeast Asian ovalocytosis","volume":"62","author":"Wrong","year":"2002","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.bcmd.2023.102778_bb0170","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2141.1991.tb08017.x","article-title":"Acquired beta thalassaemia trait in MDS","volume":"79","author":"Hoyle","year":"1991","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.bcmd.2023.102778_bb0175","doi-asserted-by":"crossref","first-page":"E325","DOI":"10.1002\/ajh.24400","article-title":"Myelodysplastic syndrome associated with acquired beta thalassemia: \u201cBTMDS\u201d","volume":"91","author":"Brunner","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.bcmd.2023.102778_bb0180","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2141.2007.06831.x","article-title":"Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders","volume":"139","author":"Steensma","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2023.102778_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2021.102618","article-title":"Red cell anarchy. Evidence of neoplastic dyserythropoiesis","volume":"92","author":"Lichtman","year":"2021","journal-title":"Blood Cells Mol. Dis."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979623000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979623000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:36:31Z","timestamp":1761050191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979623000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":37,"alternative-id":["S1079979623000554"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2023.102778","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired elliptocytosis in chronic myeloid neoplasms: An enigmatic relationship to acquired red cell membrane protein and genetic abnormalities","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2023.102778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102778"}}